Business
Cute brown puppy, sunglasses and American Flag
Getty Images
STATE OF THE UNION

As America celebrates Independence Day, the US economy is powering along

Happy July 4th — here are six charts about the economy.

As you settle in for your second, third — or maybe 70th if your name is Joey Chestnut — hot dog today, you may find yourself unwittingly entered into a conversation about the economy.

To arm you for such an event, here’s some data:

The US economy's H1 2025
Sherwood News

The reality is that, despite a slew of soft economic data — think surveys and sentiment polls — that spooked investors in the springtime, the world’s largest economy has chugged along just fine. And yesterday’s official labor market data showed that the country added another 147,000 jobs in June. Unemployment fell to just 4.1%, with trade uncertainties yet to meaningfully dent the economic data.

Of course, there are always risks. The “wall of worry” that investors have had to climb in order to get comfortable investing has been pretty substantial, with wars in Ukraine and the Middle East, continued trade uncertainty, and growing unease over the size of the federal deficit.

Even AI is a double-edged sword, with companies starting to make very real cuts to their workforces.

But dip buyers, both retail and institutional, can’t seem to kick the habit, leaving the S&P 500 Index at a record high just in time for America’s birthday.

More Business

See all Business
Strive Pharmacy recently broke ground on a new facility in Mesa, Arizona. (Strive Pharmacy)

Before Hims’ GLP-1 pill fallout, its pharmacy partner was already drawing scrutiny from state regulators

Strive has already been probed over the timing of its GLP-1 compounding. Now, Arizona regulators are looking into complaints about ketamine misuse and improper distribution of prescription drugs.

business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.